Where are we and how far is there to go in the development of an Acinetobacter vaccine?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Where are we and how far is there to go in the development of an Acinetobacter vaccine?
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2021-02-10
DOI
10.1080/14760584.2021.1887735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii
- (2020) Mohammed Bahey-El-Din et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method
- (2020) Sepideh Fereshteh et al. MICROBIAL PATHOGENESIS
- Hybrid Antigens Expressing Surface Loops of ZnuD From Acinetobacter baumannii Is Capable of Inducing Protection Against Infection
- (2020) Maryam Mobarak Qamsari et al. Frontiers in Immunology
- Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria
- (2020) Eman G. Youssef et al. Frontiers in Immunology
- Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein
- (2020) Zeinab Mahmoudi et al. APMIS
- Outer Membrane Protein, Oma87 Prevents Acinetobacter baumannii Infection
- (2020) Iraj Rasooli et al. International Journal of Peptide Research and Therapeutics
- In Silico Identification of Probable Drug and Vaccine Candidates Against Antibiotic-Resistant Acinetobacter baumannii
- (2020) Elaheh Zadeh Hosseingholi et al. Microbial Drug Resistance
- Rapid and assured genetic engineering methods applied to Acinetobacter baylyi ADP1 genome streamlining
- (2020) Gabriel A Suárez et al. NUCLEIC ACIDS RESEARCH
- Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants
- (2020) Ming-Hsien Chiang et al. Frontiers in Microbiology
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Host Innate Immune Responses to Acinetobacter baumannii Infection
- (2020) Wangxue Chen Frontiers in Cellular and Infection Microbiology
- Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model
- (2019) Shun Xin Wang-Lin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii
- (2019) Jennifer K. Singh et al. Frontiers in Microbiology
- Status of vaccine research and development for Clostridium difficile
- (2019) T.V. Riley et al. VACCINE
- Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii
- (2019) Negin Bolourchi et al. MICROBIAL PATHOGENESIS
- PanRV: Pangenome-reverse vaccinology approach for identifications of potential vaccine candidates in microbial pangenome
- (2019) Kanwal Naz et al. BMC BIOINFORMATICS
- Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery
- (2019) Sajjad Ahmad et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pushing the envelope: LPS modifications and their consequences
- (2019) Brent W. Simpson et al. NATURE REVIEWS MICROBIOLOGY
- DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection
- (2019) Langhuan Lei et al. MOLECULAR BIOLOGY REPORTS
- Vaccines and global health: In search of a sustainable model for vaccine development and delivery
- (2019) Rino Rappuoli et al. Science Translational Medicine
- Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice
- (2019) Greg Harris et al. Scientific Reports
- Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii
- (2019) Shama Mujawar et al. Frontiers in Cellular and Infection Microbiology
- Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant Acinetobacter baumannii
- (2019) Weiwei Huang et al. Frontiers in Microbiology
- The Mechanisms of Disease Caused by Acinetobacter baumannii
- (2019) Faye C. Morris et al. Frontiers in Microbiology
- A new strain of Acinetobacter baumannii and characterization of its ghost as a candidate vaccine
- (2019) S.A. Sheweita et al. Journal of Infection and Public Health
- Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection
- (2019) Zahra Aghajani et al. APMIS
- One-Step Engineering of a Stable, Selectable Marker-Free Autoluminescent Acinetobacter baumannii for Rapid Continuous Assessment of Drug Activity
- (2019) Huofeng Jiang et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection
- (2019) Jūratė Skerniškytė et al. BMC MICROBIOLOGY
- A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection
- (2019) Marina R. Pulido et al. VACCINE
- Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine
- (2018) Hao Gu et al. Aging-US
- Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine
- (2018) Hossein Ansari et al. INDIAN JOURNAL OF MICROBIOLOGY
- Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii : An innovative approach
- (2018) Abolfazl Jahangiri et al. JOURNAL OF MICROBIOLOGICAL METHODS
- An in silico structural and physicochemical characterization of TonB-dependent copper receptor in A. baumannii
- (2018) Sajad Abdollahi et al. MICROBIAL PATHOGENESIS
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection
- (2018) Marina R. Pulido et al. VACCINE
- Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii
- (2018) Vandana Solanki et al. Scientific Reports
- The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection
- (2018) Priya Uppuluri et al. PLoS Pathogens
- A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice
- (2018) Xi Zeng et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based
- (2018) Wei Cai et al. Diagnostic Pathology
- Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model
- (2018) A. Jahangiri et al. JOURNAL OF APPLIED MICROBIOLOGY
- Genome sequence analysis of an extensively drug-resistant Acinetobacter baumannii indigo-pigmented strain depicts evidence of increase genome plasticity
- (2018) German Traglia et al. Scientific Reports
- Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit
- (2018) Anne-Lise Munier et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
- (2017) Travis B Nielsen et al. JOURNAL OF INFECTIOUS DISEASES
- In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A
- (2017) Abolfazl Jahangiri et al. MICROBIAL PATHOGENESIS
- Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection
- (2017) Haitao Li et al. Molecular Medicine Reports
- Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection
- (2017) Sarah Ainsworth et al. VACCINE
- A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate
- (2017) Feng-Ling Yang et al. VACCINE
- Identification of antigens from nosocomial Acinetobacter baumannii clinical isolates in sera from ICU staff and infected patients using the antigenome technique
- (2017) Tina Nafarieh et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy
- (2017) Maria P. Cabral et al. Nature Communications
- Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
- (2017) Arif Tasleem Jan Frontiers in Microbiology
- Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin
- (2017) Ramkumar Iyer et al. ACS Infectious Diseases
- Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii
- (2017) Ravinder Singh et al. Scientific Reports
- Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets
- (2016) Afreenish Hassan et al. BMC GENOMICS
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease
- (2016) Anna L. Kenchington et al. Expert Review of Vaccines
- Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb
- (2016) Nisha Garg et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Homology modeling of a Camelid antibody fragment against a conserved region of Acinetobacter baumannii biofilm associated protein (Bap)
- (2016) Fateme Sefid et al. JOURNAL OF THEORETICAL BIOLOGY
- In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin Utilization A protein (rBauA)
- (2016) Hamid Esmaeilkhani et al. MICROBIAL PATHOGENESIS
- Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii
- (2016) Xiaojiao Zhang et al. MICROBIAL PATHOGENESIS
- Vaccines for Antibiotic-Resistant Bacteria: Possibility or Pipe Dream?
- (2016) Meritxell García-Quintanilla et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii
- (2016) Weiwei Huang et al. Scientific Reports
- An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii
- (2016) Meng-Hooi Shu et al. Scientific Reports
- Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection
- (2016) Weiwei Huang et al. Scientific Reports
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Molecular mechanisms for enhanced DNA vaccine immunogenicity
- (2015) Lei Li et al. Expert Review of Vaccines
- Acinetobacter baumanniiK27 and K44 capsular polysaccharides have the same K unit but different structures due to the presence of distinctwzygenes in otherwise closely related K gene clusters
- (2015) Alexander S Shashkov et al. GLYCOBIOLOGY
- Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection
- (2015) Farzad Badmasti et al. MOLECULAR IMMUNOLOGY
- Immunogenicity of conserved cork and β-barrel domains of baumannii acinetobactin utilization protein in an animal model
- (2015) Yaqub HAJIAGHATABAR SANGROODI et al. Turkish Journal Of Medical Sciences
- OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections
- (2015) Weiwei Huang et al. VACCINE
- Current advances and challenges in the development ofAcinetobactervaccines
- (2015) Wangxue Chen Human Vaccines & Immunotherapeutics
- Identification of novel vaccine candidates againstAcinetobacter baumanniiusing reverse vaccinology
- (2015) Ming-Hsien Chiang et al. Human Vaccines & Immunotherapeutics
- Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
- (2015) Edward Geisinger et al. PLoS Pathogens
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants
- (2015) Fei Liu et al. BMC GENOMICS
- Microbial biosynthesis of designer outer membrane vesicles
- (2014) Jenny L Baker et al. CURRENT OPINION IN BIOTECHNOLOGY
- First Steps Towards a Vaccine against Acinetobacter baumannii
- (2014) Meritxell Garcia-Quintanilla et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa
- (2014) G. P. Priebe et al. JOURNAL OF IMMUNOLOGY
- Vaccines for Acinetobacter baumannii: Thinking “out of the box”
- (2014) Federico Perez et al. VACCINE
- Attitudes to vaccination: A critical review
- (2014) Ohid Yaqub et al. SOCIAL SCIENCE & MEDICINE
- Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes
- (2013) Johanna J. Kenyon et al. PLoS One
- Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii
- (2013) Danilo G. Moriel et al. PLoS One
- Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes
- (2012) Lin Lin et al. VACCINE
- The OmpA family of proteins: Roles in bacterial pathogenesis and immunity
- (2012) Anthony W. Confer et al. VETERINARY MICROBIOLOGY
- Identification of a General O-linked Protein Glycosylation System in Acinetobacter baumannii and Its Role in Virulence and Biofilm Formation
- (2012) Jeremy A. Iwashkiw et al. PLoS Pathogens
- Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap)
- (2011) Yaser Fattahian et al. MICROBIAL PATHOGENESIS
- Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii
- (2011) Michael J. McConnell et al. VACCINE
- The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor
- (2010) T. A. Russo et al. INFECTION AND IMMUNITY
- Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity againstPseudomonas aeruginosaAcute Lung Infection
- (2010) Akinobu Kamei et al. INFECTION AND IMMUNITY
- In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii
- (2010) Mohammad Reza Rahbar et al. JOURNAL OF THEORETICAL BIOLOGY
- Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies
- (2010) Michael J. McConnell et al. PROTEIN EXPRESSION AND PURIFICATION
- Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine
- (2010) Michael J. McConnell et al. VACCINE
- A Live‐Attenuated Vaccine for the Treatment of Urinary Tract Infection by UropathogenicEscherichia coli
- (2009) Benjamin K. Billips et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started